tisagenlecleucel

Spain

Drugs containing this active substance

  • KYMRIAH 1.2 X 10E6 - 6.0 X 10E8 CELLS DISPERSION FOR INFUSION

    It is used to treat three types of white blood cell cancer: B-cell acute lymphoblastic leukemia (in children and young adults up to 25 years of age who have not responded to other treatments), diffuse large B-cell lymphoma (in adults 18 years of age or older), and follicular lymphoma (in adults 18 years of age or older).

    Form: solution for injection

    Active substance Dosage
    tisagenlecleucel 1,2 x 10e6 - 2,5 x 10e8 CELULAS

    ATC: L01X L01XL L01XL04

    Manufacturer: Novartis Europharm Limited